CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

CADTH Medical Device Portfolio Information Session

Event Date: November 24, 2020
Location: 12:00 p.m. to 1:45 p.m. EST (Zoom Webinar)
Result type: Events

Health technology assessment (HTA) plays a key role in decisions about the use of medical devices in Canada. This session will cover the role of HTA in the management of medical devices in Canada, the programs in CADTH’s medical devices and clinical interventions portfolio, and CADTH’s COVID-19 response. Updates on other relevant CADTH initiatives will also be provided. The session will include an open forum, where attendees can direct questions to CADTH President and CEO Suzanne McGurn and other senior staff at CADTH.

Questions may be sent by email to